An Insider at Bausch Health Companies is Exercising Options


Yesterday it was reported that an Insider at Bausch Health Companies (BHC), William Humphries, exercised options to sell 114,055 BHC shares for a total transaction value of $2.27M.

Following William Humphries’ last BHC Sell transaction on September 10, 2020, the stock climbed by 4.9%. In addition to William Humphries, one other BHC executive reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

The company has a one-year high of $31.97 and a one-year low of $11.15.

Based on 7 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $26.64, reflecting a -25.1% downside.

The insider sentiment on Bausch Health Companies has been negative according to 157 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts